Evidence-Based AI Is Booming—But Can Doctors Really Trust It?
Over the past year, medical AI has undergone a fundamental shift—from general-purpose question answering to evidence-based clinical decision support.
As physicians increasingly ask not just “What’s the answer?” but also “Where does this recommendation come from?”, a new category known as Evidence-Based AI has rapidly emerged at the center of the healthcare AI landscape. From OpenEvidence, now valued at over $12 billion, to a growing number of Chinese platforms such as Zhengyuanfang, Yidu Evidence AI, and Hydrogen Health, competition is no longer focused solely on model performance. Instead, the defining challenge has become one of traceable, verifiable medical evidence. (Fierce Healthcare)
So what exactly distinguishes these new evidence-based AI systems from earlier generations of medical AI? More importantly, why are so many physicians beginning to rely on them?
What Is Evidence-Based AI?
The defining characteristic of Evidence-Based AI is not its ability to generate fluent answers—it’s the transparency of its reasoning.
Traditional medical chatbots often function like exceptionally well-read students. They can summarize medical knowledge quickly and convincingly, yet users rarely know whether a recommendation comes from an official clinical guideline, a randomized clinical trial, or simply a statistical pattern learned during model training. In some cases, they may even generate citations that appear credible but do not actually exist.
Evidence-Based AI is built on a fundamentally different philosophy. Instead of placing language generation at the center, it incorporates the principles of Evidence-Based Medicine (EBM) into the model itself. Every recommendation is expected to be supported by identifiable clinical evidence.
For example, rather than simply recommending Drug A, an evidence-based system may explain:
Drug A is recommended according to the 2024 clinical guideline, Section X, supported by Level I evidence.
This approach allows physicians to review not only the recommendation itself but also the reasoning behind it. By grounding responses in traceable clinical sources, evidence-based systems aim to reduce hallucinations while increasing transparency and trust.
Why Do Doctors Need Traceable Evidence?
A correct answer and a trustworthy answer are not always the same thing.
Clinical medicine is rarely straightforward. Two patients with the same diagnosis may require completely different treatments because of differences in age, medical history, concurrent illnesses, medications, or laboratory findings.
If an AI system provides only a final recommendation without explaining how it arrived at that conclusion, physicians have little basis for determining whether the advice is appropriate for the individual patient sitting in front of them.
This is precisely why evidence transparency has become so valuable in clinical practice.
Early evaluations of evidence-based AI platforms suggest that physicians often use them not simply to obtain answers, but to retrieve supporting evidence for treatment planning, guideline consultation, medication safety checks, teaching, and quality assurance. Rather than acting as an all-knowing oracle, the AI functions more like a meticulous medical resident—showing each step of its reasoning and allowing clinicians to verify every conclusion before making a final decision.
How Is Zhengyuanfang Performing in Practice?
Public benchmark results suggest that Zhengyuanfang has achieved competitive performance across several professional medical evaluations.
According to publicly released information, the system achieved a perfect score on the CMB2023 Chinese National Medical Licensing Examination benchmark, becoming one of the first domestic medical AI systems to do so. The platform has also reported strong results on more advanced specialist-level oncology examinations that require complex clinical reasoning.
Commercial adoption has likewise accelerated. Financial disclosures from its parent company indicate continued growth in revenue, user adoption, and AI usage throughout 2025 and 2026. Company reports also indicate that the platform now supports clinicians across numerous hospitals in China and provides evidence-based decision support to tens of thousands of healthcare professionals.
Perhaps the most telling indicator is usage itself. Rapid increases in AI inference requests suggest that physicians are integrating the system into their daily workflows rather than treating it as an occasional experimental tool.
Is China Catching Up—or Pulling Ahead?
While overseas platforms such as OpenEvidence have demonstrated remarkable growth by grounding AI responses in peer-reviewed medical literature, their knowledge bases remain primarily focused on Western clinical research and practice guidelines. OpenEvidence itself has differentiated its platform by licensing authoritative medical content from organizations such as the American Medical Association, The New England Journal of Medicine, and the JAMA Network, helping build physician trust through evidence-backed responses. (Fierce Healthcare)
For Chinese physicians, however, localization presents additional challenges.
Drug formularies, reimbursement policies, clinical pathways, and national treatment guidelines often differ substantially from those used in North America and Europe. As a result, recommendations generated from exclusively Western evidence may not always align with routine clinical practice in China.
Domestic evidence-based AI platforms have therefore focused on integrating large-scale Chinese medical literature, national clinical guidelines, and local healthcare policies alongside international evidence. The objective is not to replace global evidence but to combine international best practices with locally applicable clinical standards, allowing physicians to consider both perspectives during decision-making.
Beyond Question Answering
Evidence-Based AI is already evolving beyond conversational interfaces.
One emerging direction is real-time clinical assistance.
Recent demonstrations have shown how wearable devices such as AI-powered smart glasses can extend evidence-based decision support directly into hospital rounds, outpatient consultations, and multidisciplinary case discussions. Instead of waiting for physicians to type questions into a chatbot, these systems can capture spoken conversations, organize clinical information automatically, retrieve relevant guidelines in real time, and highlight important risk factors during patient encounters.
Another promising development is multi-agent clinical reasoning.
Rather than relying on a single large language model to perform every task, modern medical AI systems increasingly divide complex clinical problems among specialized AI agents. One agent retrieves literature, another evaluates guideline recommendations, another synthesizes evidence, while another documents the reasoning process. The result is a more transparent, modular workflow that mirrors how multidisciplinary medical teams collaborate in real clinical practice.
Will Evidence-Based AI Replace Doctors?
Probably not.
Its role is better understood as an evidence assistant rather than a physician replacement.
Around the world, regulators continue to emphasize that AI should support—not replace—clinical decision-making. Increasingly, evaluation frameworks focus not only on accuracy but also on explainability, evidence quality, safety, ethics, and regulatory compliance.
Ultimately, the qualities that define excellent physicians—clinical judgment, communication, empathy, and the ability to navigate uncertainty—remain beyond the reach of today’s AI systems.
What Evidence-Based AI can do is remove much of the repetitive work that consumes physicians’ time: searching thousands of research papers, comparing clinical guidelines, evaluating evidence quality, and documenting findings.
By allowing doctors to spend less time searching for information and more time caring for patients, evidence-based AI has the potential to improve both efficiency and quality of care.
If current progress continues, the future of medical AI may not be an autonomous doctor, but an intelligent evidence assistant—one that accompanies every clinician, provides transparent reasoning in real time, and makes high-quality medical knowledge accessible wherever patients receive care.